Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Let's see $1+ again very soon with such low float - 14,743,249.
BHPA SECURITY DETAILS
Share Structure
Market Cap Market Cap
6,962,872
08/03/2022
Authorized Shares
975,000,000
08/01/2022
Outstanding Shares
331,565,346
08/01/2022
Restricted
316,479,964
08/01/2022
Unrestricted
15,085,382
08/01/2022
Held at DTC
9,275,928
08/01/2022
Float
14,743,249
06/29/2021
Par Value
0.001
https://www.otcmarkets.com/stock/BHPA/security
Opps, I missed the yield sign. They did post an attorney letter on 08/02.
https://www.otcmarkets.com/stock/BHPA/disclosure
https://www.otcmarkets.com/otcapi/company/financial-report/341081/content
So, nothing is going to happened.
https://www.otcmarkets.com/stock/BHPA/disclosure
Yield sign off. back to pink limited.
Only annual reports are audited on OTC if I am not wrong.
Finally, corrected float on amended 2 annual filings. Now, let hear some real news!
moneymaker34: Where's the news you said was coming 2 weeks ago?
KWBT will be relisted and trading within the next 6-9 months, imho.
Kiwa is almost back to the full operation,
The cooperation with Global is still exist.
good news this week i promise
What is the current status? Where is the news you said was coming last week?
Anything good here? tia
Can you post the email? tia.
That's right! Update could be anyday next week!!!
You're asking the wrong person here.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169455753
ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products
Press Release | 06/22/2022
LOS ANGELES, June 22, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces plans to conduct additional internal quality control testing for their new Vitastem products. Vitastem and Vitastem Ultra are manufactured at a contract facility in the United States and have successfully undergone all standard testing required by regulators. Following extensive consultation with the Company’s manufacturing partners and potential purchasers and distributors of the products, the decision was made to implement further testing as an additional precautionary measure since both products are using new formulations.
The new and improved Vitastem and Vitastem Ultra are FDA-registered drugs and are among the strongest and most effective topical antibiotics available on the market. Vitastem kills all harmful Gram-positive and Gram-negative bacteria that have been available for testing (bacteria that is associated with acne, cuts, scrapes, burns, and secondary infections associated with psoriasis and eczema). Vitastem Ultra uses bacitracin as the active ingredient and the new formula is clear and colorless compared to the brownish color of the original (which has tetracycline as the active ingredient), so it will not stain the skin, fingernails, toenails, or anywhere else it is applied. Both Vitastem and Vitastem Ultra work similarly and provide the same great results. The new formulation with bacitracin provides an alternative for consumers who are allergic or resistant to one or the other.
President and CEO, Dr. Chris Otiko said, “Since both of these products are a new and improved formulation, we decided now would be the best time to conduct additional testing before we begin large scale distribution.”
Dr. Otiko continued, “The products have tested well so far, and we expect they will continue to do so without issue, but because they are both different formulations than the original, and since we are moving much closer to having to fulfill large purchase orders, we felt we should implement these precautionary measures at this time in an abundance of caution. The last thing we want is to have a problem down the road when a correction would be much harder to address. Taking this step now will minimize the potential for such problems later.”
The Company expects the additional testing will be completed within four weeks and product distribution is expected to commence soon after.
About ViaDerma, Inc.
ViaDerma, Inc. (OTC: VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. For more information, visit: www.viadermalicensing.com
Any forecast of future performance is a "forward looking statement" under securities laws. Such statements are included to allow potential investors the opportunity to understand management’s beliefs and opinions with respect to the future so that they may use such beliefs and opinions as one factor among many in evaluating an investment.
Contact information:
Investor Relations
Email: info@viadermalicensing.com
Phone: 310-734-6111
Follow us on Twitter: ViaDerma Official @viaderma
Like us on Facebook: ViaDerma-VDRM @viadermapharma
https://www.otcmarkets.com/stock/VDRM/news/ViaDerma-Announces-the-Implementation-of-Internal-Quality-Control-Measures-for-its-New-Vitastem-Products?id=362199
VDRM SECURITY DETAILS
Share Structure
Market Cap Market Cap
7,553,714
07/21/2022
Authorized Shares
1,000,000,000
07/08/2022
Outstanding Shares
983,556,451
07/08/2022
Restricted
69,456,186
07/08/2022
Unrestricted
914,100,265
07/08/2022
Held at DTC
902,867,184
07/08/2022
Float
911,600,265
07/23/2021
Par Value
0.001
https://www.otcmarkets.com/stock/VDRM/security
KWBT SECURITY DETAILS
Share Structure
Market Cap Market Cap
185,050
07/21/2022
Authorized Shares
3,000,000,000
07/21/2022
Outstanding Shares
616,834,501
07/21/2022
Restricted
42,664,165
07/21/2022
Unrestricted
574,170,336
07/21/2022
Held at DTC
572,340,044
07/21/2022
Float
265,529,491
05/29/2020
Par Value
Not Available
https://www.otcmarkets.com/stock/KWBT/security
She replied the cooperation with Global still exist, or words to that effect
Pink Current Information
Caveat Emptor
Transfer Agent Verified
https://www.otcmarkets.com/stock/DIGAF/quote
Warning! This security is eligible for Unsolicited Quotes Only
This stock is not eligible for proprietary broker-dealer quotations. All quotes in this stock reflect unsolicited customer orders. Unsolicited-Only stocks have a higher risk of wider spreads, increased volatility, and price dislocations. Investors may have difficulty selling this stock. An initial review by a broker-dealer under SEC Rule15c2-11 is required for brokers to publish competing quotes and provide continuous market making.
https://www.otcmarkets.com/stock/DIGAF/quote
DIGAF SECURITY DETAILS
Share Structure
Market Cap Market Cap
1,729,310
07/19/2022
Authorized Shares
Unlimited
07/08/2022
Outstanding Shares
1,729,310,270
07/08/2022
Restricted
31,014,431
07/08/2022
Unrestricted
1,698,295,839
07/08/2022
Held at DTC
1,698,228,627
07/08/2022
Float
368,513,533
11/05/2019
Par Value
No Par Value
https://www.otcmarkets.com/stock/DIGAF/security
Looks like DIGAF is trading again.
That will have to be after DIGAF is relisted and trading somehow. Let's see...
Only if the news is DIGAF back to trading again somehow.
0.01's this week before news would be nice. Hopefully, 0.02 - 0.05+ after this news.
Let's hope this is the week $CGAC gets that r/m news and starts a major run to pennies.
Come on, $VDRM! 0.05-0.10+ run starting next week!
Don't think anyone can save DIGAF at this point. It's done. Brad has done it.
KWBT SECURITY DETAILS
Share Structure
Market Cap Market Cap
123,367
07/11/2022
Authorized Shares
3,000,000,000
07/05/2022
Outstanding Shares
616,834,501
07/05/2022
Restricted
42,664,165
07/05/2022
Unrestricted
574,170,336
07/05/2022
Held at DTC
572,340,044
07/05/2022
Float
265,529,491
05/29/2020
Par Value
Not Available
https://www.otcmarkets.com/stock/KWBT/security
How is that even possible?
DIGAF is still suspended, on grey market and Caveat Emptor status.
https://www.otcmarkets.com/stock/DIGAF/profile
Come on now, that's the good news? WTF!
What happened to r/m? back to apparel industry? tia.
They spent so much money acquiring the EMPM shell since 2-3 years ago and they still own 67% of the OS in restricted shares. They also spent a lot of money to regain control of the shell this past year.
EMPM has 195,837,336 shares in the OS
with 131,860,669 Restricted shares a/s 10/18/2021.
Do EMPM/Saean shares get 1-1 r/m into GPSI/GPSID shell?
We have been waiting for more than 2 years+.
I listened to almost every Hearing last year, and read most of the legal documents. Saean/Dr. Lee really wanted control of this shell, fought hard and spent a great deal of time/money to regain control. Against all odds, they finally got it too, via court Order. My gut tells me the merger thing is still happening, but perhaps in a way we didn't think of. We still own shares in a company (now private), of which Saean has over 64% stake. Saean is a global company with multiple subsidiaries.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168071363
Thanks, so SEAN is going forward with GPSID r/m.
GPSID - Saean Group Inc.'s OS is only 200k after 500-1 R/S.
There is plenty of room for EMPM/Saean to r/m into GPSID/Saean GRoup Inc. Shell.
Yes, that's what I had been saying.
Hopefully, $NDTP to pink current status in July.
What are you hearing, Moneymaker34? Please share with the board.
let's hope and see if we get a mega run to at least 0.025+ in coming months...
That's not good.